Procter & Gamble Co (NYSE:PG) Expected to Announce Quarterly Sales of $16.87 Billion

Wall Street analysts forecast that Procter & Gamble Co (NYSE:PG) will announce sales of $16.87 billion for the current quarter, according to Zacks. Seven analysts have provided estimates for Procter & Gamble’s earnings, with estimates ranging from $16.57 billion to $17.25 billion. Procter & Gamble posted sales of $16.50 billion in the same quarter last year, which would indicate a positive year over year growth rate of 2.2%. The firm is scheduled to issue its next quarterly earnings results before the market opens on Tuesday, July 30th.

On average, analysts expect that Procter & Gamble will report full-year sales of $67.46 billion for the current fiscal year, with estimates ranging from $67.16 billion to $67.84 billion. For the next financial year, analysts expect that the firm will post sales of $69.78 billion, with estimates ranging from $68.36 billion to $70.40 billion. Zacks’ sales averages are a mean average based on a survey of sell-side research analysts that follow Procter & Gamble.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings results on Tuesday, April 23rd. The company reported $1.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.04 by $0.02. Procter & Gamble had a net margin of 16.44% and a return on equity of 21.61%. The firm had revenue of $16.46 billion for the quarter, compared to analyst estimates of $16.37 billion. During the same period in the previous year, the business earned $1.00 EPS. The company’s revenue was up 1.1% compared to the same quarter last year.

A number of research analysts have recently commented on PG shares. Morgan Stanley set a $111.00 price objective on shares of Procter & Gamble and gave the company a “buy” rating in a research report on Thursday, March 28th. Scotiabank reissued a “buy” rating on shares of Procter & Gamble in a research report on Friday. Goldman Sachs Group raised shares of Procter & Gamble from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $114.00 to $125.00 in a research report on Thursday, June 27th. Deutsche Bank lifted their price objective on shares of Procter & Gamble from $106.00 to $109.00 and gave the company a “hold” rating in a research report on Monday, June 17th. Finally, Credit Suisse Group set a $100.00 price objective on shares of Procter & Gamble and gave the company a “hold” rating in a research report on Friday, May 10th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the stock. Procter & Gamble currently has a consensus rating of “Hold” and a consensus price target of $102.32.

Shares of PG traded down $1.14 during midday trading on Thursday, reaching $112.91. The stock had a trading volume of 5,344,826 shares, compared to its average volume of 7,136,900. The company’s 50 day simple moving average is $109.03. Procter & Gamble has a one year low of $77.54 and a one year high of $114.27. The stock has a market cap of $283.82 billion, a price-to-earnings ratio of 26.76, a PEG ratio of 3.43 and a beta of 0.45. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.60 and a current ratio of 0.79.

In other Procter & Gamble news, insider Deborah P. Majoras sold 6,161 shares of Procter & Gamble stock in a transaction dated Thursday, April 25th. The shares were sold at an average price of $103.10, for a total value of $635,199.10. Following the completion of the sale, the insider now owns 44,996 shares in the company, valued at approximately $4,639,087.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO David S. Taylor sold 30,000 shares of Procter & Gamble stock in a transaction dated Friday, April 26th. The stock was sold at an average price of $105.00, for a total transaction of $3,150,000.00. Following the completion of the sale, the chief executive officer now owns 256,088 shares of the company’s stock, valued at approximately $26,889,240. The disclosure for this sale can be found here. Insiders have sold a total of 320,840 shares of company stock valued at $33,904,086 in the last ninety days. 1.84% of the stock is currently owned by insiders.

Institutional investors have recently modified their holdings of the business. Vanguard Group Inc. raised its position in shares of Procter & Gamble by 0.5% in the 3rd quarter. Vanguard Group Inc. now owns 188,401,646 shares of the company’s stock valued at $15,680,670,000 after buying an additional 853,269 shares in the last quarter. Vanguard Group Inc raised its position in shares of Procter & Gamble by 0.5% in the 3rd quarter. Vanguard Group Inc now owns 188,401,646 shares of the company’s stock valued at $15,680,670,000 after buying an additional 853,269 shares in the last quarter. FMR LLC raised its position in shares of Procter & Gamble by 26.4% in the 1st quarter. FMR LLC now owns 35,400,538 shares of the company’s stock valued at $3,683,425,000 after buying an additional 7,389,251 shares in the last quarter. Bank of New York Mellon Corp raised its position in shares of Procter & Gamble by 3.2% in the 4th quarter. Bank of New York Mellon Corp now owns 25,152,723 shares of the company’s stock valued at $2,312,039,000 after buying an additional 775,146 shares in the last quarter. Finally, Morgan Stanley raised its position in shares of Procter & Gamble by 11.3% in the 3rd quarter. Morgan Stanley now owns 17,584,133 shares of the company’s stock valued at $1,463,528,000 after buying an additional 1,784,225 shares in the last quarter. Institutional investors and hedge funds own 62.24% of the company’s stock.

Procter & Gamble Company Profile

The Procter & Gamble Company provides branded consumer packaged goods to consumers in North America, Europe, the Asia Pacific, Greater China, Latin America, India, the Middle East, and Africa. The company operates in five segments: Beauty; Grooming; health Care; fabric & Home Care; and Baby, Feminine & Family Care.

Featured Article: Stock Portfolio Tracker

Get a free copy of the Zacks research report on Procter & Gamble (PG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.